Mastering Asparaginase Regimens in the Care of Pediatric and AYA Patients With Acute Lymphoblastic Leukemia

This program will help to effectively personalize the care of pediatric and adolescent and young adult patients with acute lymphoblastic leukemia and provide expert perspectives on how to optimize clinical outcomes with the use of asparaginase-based therapy, including information on evidence-based strategies to effectively prevent, mitigate, and manage associated adverse events. After the live symposium, view the on-demand webcast and download the associated slideset for use in your clinic.

Share

Program Content

Activities

Asparaginase in Pediatric ALL
Overview of Asparaginase Formulations in Pediatric ALL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 01, 2024

Expires: March 31, 2025

Asparaginase Considerations in ALL
Practical Considerations for Asparaginase-Based Therapy in ALL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 01, 2024

Expires: March 31, 2025

Activities

Asparaginase for Acute Lymphoblastic Leukemia
Mastering Asparaginase Regimens in the Care of Pediatric and AYA Patients With Acute Lymphoblastic Leukemia
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 17, 2024

Expires: April 16, 2025

Faculty

cover img faculity

Emily Curran, MD

Assistant Professor
Department of Internal Medicine
Division of Hematology and Oncology
University of Cincinnati Cancer Center
Cincinnati, Ohio

cover img faculity

Stephen P. Hunger, MD

Jeffrey E. Perelman Distinguished Chair in Pediatrics
Chief, Division of Pediatric Oncology
Director, Center for Childhood Cancer Research
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.